Radiolucent kidney stones are the most common clinical manifestation, followed by chronic kidney disease which has already progressed to end-stage kidney disease in 15–20% of patients at the time of diagnosis of APRT deficiency [2]. This evidence concerns the gene APRT and chronic kidney disease.